COX-2 inhibition and prostaglandin receptors in experimental nephritis

European Journal of Clinical Investigation

Volumn 33, Issue 11, 2003, Pages 969-975

  Waldner, C ^a   Heise, G ^a   Schror K ^a   Heering, P ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

Author keywords

COX 2; Glomerulonephritis; Passive Heymann nephritis; Prostaglandin receptors

Indexed keywords

BICYCLO COMPOUND; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; PROSTACYCLIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3 RECEPTOR; PROSTAGLANDIN E4 RECEPTOR; RECEPTOR SUBTYPE; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEYMANN NEPHRITIS; KIDNEY CORTEX; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; ISOENZYMES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES;

EID: 0242552908     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01256.x     Document Type: Article

References (26)

1. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 2000;279:F965-F981.
2. Wagner C, Jensen BL, Krämer BK, Kurtz A. Control of the renal renin system by local factors. Kidney Int 1998;55 (Suppl. 67):S78-S83.
3. Walker LA, Frölich JC. Renal prostaglandins and leukotrienes. Rev Physiol Biochem Pharmacol 1987;107:1-72.
4. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13S-24S.
5. Wolf G, Porth J, Stahl RA. Acute renal failure associated with rofecoxib. Ann Intern Med 2000;133:394.
6. Alper ABJ, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis 2002;40:1086-90.
7. Graham MG. Acute renal failure related to high-dose celecoxib. Ann Intern Med 2001;135:69-70.
8. Perazella MA, Eras J. Are selective COX-2 inhibitors nephrotoxic? Am J Kid Dis 2000;35:937-40.
9. Rocha JL, Fernandez-Alonso J. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. Lancet 2001;357:1946-7.
10. Breyer MD. Prostaglandin receptors in the kidney: a new route for intervention? Exp Nephrol 1998;6:180-8.
11. Audoly LP, Ruan XP, Wagner VA, Goulet JL, Tilley SL, Koller BH et al. Role of EP2 and EP3 PGE (2) receptors in control of murine renal hemodynamics. Am J Physiol Heart Circ Physiol 2001;280:H327-H333.
12. Tilley SL, Audoly LP, Hicks EH, Kim HS, Flannery PJ, Coffman TM et al. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest 1999;103:1539-45.
13. Ueno A, Matsumoto H, Naraba H, Ikeda Y, Ushikubi F, Matsuoka T et al. Major roles of prostanoid receptors IP and EP (3) in endotoxin-induced enhancement of pain perception. Biochem Pharmacol 2001;62:157-60.
14. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998;395:281-4.
15. Nataraj C, Thomas DW, Tilley SL, Nguyen MT, Mannon R, Kobayashi T et al. Receptors for prostaglandin E (2) that regulate cellular immune responses in the mouse. J Clin Invest 2001;108:1229-35.
16. Komhoff M, Lesener B, Nakao K, Seyberth HW, Nusing RM. Localization of the prostacyclin receptor in human kidney. Kidney Int 1998;54:1899-908.
17. Morath R, Klein T, Seyberth HW, Nusing RM. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol 1999;10:1851-60.
18. Jensen BL, Mann B, Skott O, Kurtz A. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat. Kidney Int 1999;56:528-37.
19. Hartner A, Pahl A, Brune K, Goppelt-Strübe M. Upregulation of cyclooxygenase-1 and the PGE (2) receptor EP2 in rat and human mesangioproliferative glomerulonephritis. Inflamm Res 2000;49:345-54.
20. Blume C, Heise G, Mühlfeld A, Bach D, Schrör K, Gerhardz CD et al. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat. Kidney Int 1999;56:1770-8.
21. Schrör K, Seidel H. Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system. Arch Pharmacol 1988;337:177-82.
22. Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. J Clin Invest 1995;96:657-64.
23. Waldner C, Heise G, Meyer-Kirchrath J, Schrör K, Grabensee B, Heering P. Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha-v integrin expression. Nephron Exp Nephrol 2003;93 (2):: e72-e79.
24. Takano T, Cybulsky AV, Yang X, Aoudjit L. Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells. Am J Physiol Renal Physiol 2001;281:F841-F850.
25. Ferguson S, Hebert RL, Laneuville O. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. J Am Soc Nephrol 1999;10:2261-71.
26. Nasrallah R, Laneuville O, Ferguson S, Hebert RL. Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells. Am J Physiol Renal Physiol 2001;281:F132.